Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does UPADACITINIB Cause Obesity? 41 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Obesity have been filed in association with UPADACITINIB (Rinvoq). This represents 0.1% of all adverse event reports for UPADACITINIB.

41
Reports of Obesity with UPADACITINIB
0.1%
of all UPADACITINIB reports
12
Deaths
25
Hospitalizations

How Dangerous Is Obesity From UPADACITINIB?

Of the 41 reports, 12 (29.3%) resulted in death, 25 (61.0%) required hospitalization, and 11 (26.8%) were considered life-threatening.

Is Obesity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 41 reports have been filed with the FAERS database.

What Other Side Effects Does UPADACITINIB Cause?

Pain (4,444) Arthralgia (3,815) Drug ineffective (3,384) Covid-19 (2,978) Rheumatoid arthritis (2,730) Pain in extremity (2,353) Fatigue (2,153) Fall (2,081) Surgery (2,037) Therapy interrupted (1,741)

What Other Drugs Cause Obesity?

RISPERIDONE (3,039) PREDNISONE (1,880) METHOTREXATE (1,876) ADALIMUMAB (1,780) TOCILIZUMAB (1,630) ABATACEPT (1,605) INFLIXIMAB (1,536) HYDROXYCHLOROQUINE (1,532) SULFASALAZINE (1,455) ETANERCEPT (1,407)

Which UPADACITINIB Alternatives Have Lower Obesity Risk?

UPADACITINIB vs URAPIDIL UPADACITINIB vs UREA UPADACITINIB vs URIDINE TRIACETATE UPADACITINIB vs UROFOLLITROPIN UPADACITINIB vs URSODIOL

Related Pages

UPADACITINIB Full Profile All Obesity Reports All Drugs Causing Obesity UPADACITINIB Demographics